Benitec Biopharma (BNTC) Invested Capital (2019 - 2025)
Benitec Biopharma (BNTC) has disclosed Invested Capital for 7 consecutive years, with -$219.4 million as the latest value for Q1 2025.
- Quarterly Invested Capital fell 2007.57% to -$219.4 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was -$219.4 million through Mar 2025, down 2007.57% year-over-year, with the annual reading at $47.2 million for FY2024, 23290.1% up from the prior year.
- Invested Capital hit -$219.4 million in Q1 2025 for Benitec Biopharma, down from $1000.0 in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $47.2 million in Q2 2024 to a low of -$219.4 million in Q1 2025.
- Historically, Invested Capital has averaged -$13.1 million across 5 years, with a median of $10.8 million in 2021.
- Biggest five-year swings in Invested Capital: skyrocketed 23290.1% in 2024 and later plummeted 2007.57% in 2025.
- Year by year, Invested Capital stood at $10.8 million in 2021, then fell by 17.0% to $9.0 million in 2022, then skyrocketed by 72.0% to $15.5 million in 2023, then tumbled by 99.99% to $1000.0 in 2024, then plummeted by 21937200.0% to -$219.4 million in 2025.
- Business Quant data shows Invested Capital for BNTC at -$219.4 million in Q1 2025, $1000.0 in Q4 2024, and -$195.3 million in Q3 2024.